Phase 2 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 75 years of age who are able to understand and sign a consent form voluntarily.
- People who have been diagnosed with early-stage liver cancer (BCLC stage 0 or A), confirmed by tissue testing or approved imaging methods.
- People who are already scheduled to have surgery to remove the liver cancer with the aim of curing it.
- People whose results from a special pre-surgery computer analysis (called a PRE score) indicate a higher risk of the cancer coming back aggressively (a score of 0.5 or higher).
- People whose liver is functioning well, as measured by a standard scoring system called Child-Pugh class A (score of 7 or below).
- People who are fully active or have only minor limitations in daily activity, as rated on a standard medical scale (ECOG score of 0 or 1).
- People who have had a standard pre-surgery MRI scan — including multiple imaging phases — taken within one month before joining the trial, with acceptable image quality.
- People who are willing and able to attend follow-up appointments for at least 2 years.
Who may not be able to join:
- People whose tissue analysis after surgery shows a type of cancer other than hepatocellular carcinoma (for example, bile duct cancer or a mixed tumour type).
- People who have had another active cancer within the past 5 years, except for certain low-risk or successfully treated cancers such as some cervical or skin cancers (confirm with trial site).
- People who pass away or are lost to follow-up within 90 days after surgery.
- People who have a known allergic reaction to any of the treatment medications used in this trial, which may include oxaliplatin, fluorouracil, PD-1 inhibitors, or lenvatinib.
- People with serious, uncontrolled health conditions such as severe heart failure, severe kidney problems, or uncontrolled high blood pressure.
- People who have any other condition that the trial doctor believes would make safe participation or accurate assessment of results difficult.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613636076910
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
2-year Recurrence-free Survival (RFS) Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.